According to a report by Reuters, on Wednesday, Johnson and Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record 4.69 billion dollars to 22 women who blamed their ovarian cancer on asbestos in the company's Baby Powder and other talc products. Court records show...
Johnson & Johnson has reported better than expected earnings for it's fourth quarter of 2018.
Business Insider reports that shares were sliding, down 1.39%.
The company's 2019 full-year guidance fell..
· Pharmaceutical giant Johnson and Johnson is buying surgical robotics company Auris Health for $3.4 billion.
· "In this new era of health care, we're aiming... Business Insider Also reported by •bizjournals •Reuters •WorldNews •Wall Street Journal